EQAL
Price
$58.86
Change
+$0.21 (+0.36%)
Updated
Oct 26, 04:56 PM (EDT)
Net Assets
816.19M
Intraday BUY SELL Signals
VZ
Price
$43.10
Change
-$1.56 (-3.49%)
Updated
Oct 26, 04:59 PM (EDT)
Capitalization
185.55B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

EQAL vs VZ

EQAL vs VZ Comparison Chart in %
View a ticker or compare two or three
VS
EQAL vs. VZ commentary
Oct 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQAL is a StrongBuy and VZ is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EQAL with price predictions
Oct 23, 2026

EQAL in upward trend: price may jump up because it broke its lower Bollinger Band on September 28, 2026

EQAL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 37 cases where EQAL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EQAL's RSI Oscillator exited the oversold zone, 22 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on EQAL as a result. In 72 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for EQAL just turned positive on October 06, 2026. Looking at past instances where EQAL's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.

Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where EQAL advanced for three days, in 284 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQAL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for EQAL entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
a Summary for VZ with price predictions
Oct 23, 2026

VZ's RSI Indicator ascends from oversold territory

The RSI Oscillator for VZ moved out of oversold territory on October 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 28 of the 36 cases the stock moved higher. This puts the odds of a move higher at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on VZ as a result. In 38 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 46%.

The Moving Average Convergence Divergence (MACD) for VZ just turned positive on October 16, 2026. Looking at past instances where VZ's MACD turned positive, the stock continued to rise in 27 of 47 cases over the following month. The odds of a continued upward trend are 57%.

Following a +3.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where VZ advanced for three days, in 144 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.

VZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

VZ moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VZ crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 22 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.

The Aroon Indicator for VZ entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. VZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.786) is normal, around the industry mean (1.855). P/E Ratio (11.630) is within average values for comparable stocks, (-3.989). Projected Growth (PEG Ratio) (0.830) is also within normal values, averaging (8.005). Dividend Yield (0.063) settles around the average of (0.122) among similar stocks. P/S Ratio (1.509) is also within normal values, averaging (5.777).

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

FUNDAMENTALS RATINGS
VZ: Fundamental Ratings
VZ
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EQALVZ
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
53%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
46%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
43%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 13 days ago
46%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 22 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
39%
View a ticker or compare two or three
EQAL
Daily Signal:
Gain/Loss:
VZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

EQAL and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQAL has been loosely correlated with ROKU. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if EQAL jumps, then ROKU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQAL
1D Price
Change %
EQAL100%
-0.51%
ROKU - EQAL
50%
Loosely correlated
-0.92%
CMCSA - EQAL
44%
Loosely correlated
-0.66%
CSCO - EQAL
43%
Loosely correlated
+1.53%
MSI - EQAL
33%
Loosely correlated
+0.84%
VZ - EQAL
32%
Poorly correlated
-1.19%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.240.01
+2.65%
AEON Biopharma
DXCM77.94-0.38
-0.49%
DexCom
SPFI43.02-0.91
-2.07%
South Plains Financial
GUTS1.08-0.05
-4.42%
Fractyl Health Inc.
TNGX23.34-4.59
-16.43%
Tango Therapeutics